Inhibition methylprednisolone leukocyte-induced pulmonary damage BACKGROUND METHODS purpose study development chronic model leukocyte-mediated pulmonary injury evaluation protective effects methylprednisolone Rabbits ip zymosan Blood gases leukocytes Survivors day microscopic studies evaluation lung lipid peroxidation by-product malondialdehyde RESULTS Intraperitoneal zymosan marked decrease leukocytes cellularity alveolar septa interstitial edema lung malondialdehyde Pulmonary damage methylprednisolone zymosan inoculation methylprednisolone hr CONCLUSIONS authors local nonseptic inflammatory stimulus changes lungs methylprednisolone process onset inflammation 